[Changes in serum inflammatory factors in wheezing infants with community-acquired pneumonia]

Area of Science:

• Pediatric Pulmonology
• Immunology
• Respiratory Medicine

Background:

• Community-acquired pneumonia (CAP) is common in infants.
• Wheezing is a frequent symptom in pediatric respiratory infections.
• The immune mechanisms underlying infantile wheezing pneumonia remain unclear.

Purpose of the Study:

• To investigate the immune mechanisms of infantile wheezing pneumonia.
• To compare serum inflammatory factor levels in infants with and without wheezing due to CAP.
• To determine if infantile wheezing pneumonia shares immune pathways with asthma.

Main Methods:

• Comparative study involving three groups: infants with CAP without wheezing (42), infants with CAP and wheezing (47), and healthy controls (30).
• Measurement of serum inflammatory markers: C-reactive protein, procalcitonin, soluble triggering receptor expressed on myeloid cell-1 (sTREM-1), interferon-γ (IFN-γ), interleukin-4 (IL-4), interleukin-10 (IL-10), and periostin.
• Statistical analysis to compare marker levels and ratios between groups.

Main Results:

• Serum levels of procalcitonin, sTREM-1, IL-4, and IL-10 were elevated in both CAP groups compared to controls.
• The interferon-γ/interleukin-4 ratio was significantly lower in the wheezing pneumonia group versus non-wheezing pneumonia and control groups.
• Periostin levels were higher in the wheezing pneumonia group compared to the other two groups.

Conclusions:

• The findings suggest that infantile pneumonia with wheezing may share immune mechanisms with asthma.
• An unbalanced interferon-γ/interleukin-4 ratio indicates a shift towards Th2-mediated inflammation.
• Elevated periostin points towards airway eosinophilic inflammation, a hallmark of allergic asthma.